Precision Drilling
PDS
SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(Q3)Sep 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.50%5.46B | 4.79B | -12.90%25.55B | 5.33B | -18.37%29.33B | 6.37%35.93B | -3.46%33.78B | 2.72%35B | 36.09%34.07B | 9.01%25.03B |
Operating revenue | 2.50%5.46B | --4.79B | -12.90%25.55B | --5.33B | -18.37%29.33B | 6.37%35.93B | -3.46%33.78B | 2.72%35B | 36.09%34.07B | 9.01%25.03B |
Cost of revenue | -5.11%4.61B | 4.13B | -11.85%21.79B | 4.86B | 1.33%24.72B | 18.37%24.39B | -1.55%20.61B | 1.97%20.93B | 18.51%20.53B | 3.88%17.32B |
Gross profit | 81.02%852.87M | 661.52M | -18.51%3.76B | 471.14M | -60.01%4.62B | -12.40%11.54B | -6.32%13.18B | 3.86%14.07B | 75.58%13.54B | 22.61%7.71B |
Operating expense | 9.03%567.77M | 549.23M | -1.36%2.77B | 520.76M | -27.53%2.81B | -2.10%3.88B | 8.91%3.96B | -2.04%3.64B | 3.59%3.72B | 4.13%3.59B |
Selling and administrative expenses | 9.03%567.77M | --549.23M | -2.34%2.83B | --520.76M | -29.88%2.9B | -1.77%4.13B | 8.47%4.2B | -2.56%3.88B | 6.76%3.98B | 4.63%3.73B |
-Selling and marketing expense | -16.66%107.49M | --101.48M | 11.19%506.24M | --128.97M | -73.02%455.28M | 11.47%1.69B | -15.18%1.51B | 2.36%1.78B | 16.98%1.74B | -0.68%1.49B |
-General and administrative expense | 17.48%460.28M | --447.76M | -4.86%2.32B | --391.78M | -0.10%2.44B | -9.22%2.44B | 28.65%2.69B | -6.40%2.09B | -0.05%2.23B | 8.50%2.24B |
Operating profit | 674.55%285.1M | 112.29M | -45.24%987.98M | -49.62M | -76.46%1.8B | -16.83%7.66B | -11.63%9.21B | 6.10%10.43B | 138.15%9.83B | 44.98%4.13B |
Net non-operating interest income expense | -2.65%-140.24M | -137.04M | -128.10%-458.06M | -136.63M | -277.77%-200.82M | 15.12%-53.16M | 77.08%-62.63M | 39.02%-273.19M | 5.90%-448.02M | 18.22%-476.08M |
Non-operating interest income | ---- | ---- | -22.57%77.76M | ---- | -26.29%100.42M | -19.01%136.23M | 25.22%168.21M | 14.44%134.33M | 104.77%117.38M | 51.69%57.32M |
Non-operating interest expense | 2.65%140.24M | --137.04M | 77.87%535.81M | --136.63M | 59.06%301.24M | -17.96%189.38M | -43.36%230.83M | -27.92%407.52M | 6.00%565.39M | -13.95%533.4M |
Other net income (expense) | ||||||||||
Special income (charges) | ---- | ---- | -2.27%257.21M | ---- | 263.23%263.19M | 3.81%72.46M | 49.39%69.8M | 61.89%46.73M | 8.14%28.86M | 37.08%26.69M |
-Less:Other special charges | ---- | ---- | 2.27%-257.21M | ---- | -263.23%-263.19M | -3.81%-72.46M | -49.39%-69.8M | -61.89%-46.73M | -8.14%-28.86M | -37.08%-26.69M |
Other non- operating income (expenses) | -78.16%82.69M | --56.29M | 43.62%182.56M | --378.64M | -10.53%127.11M | 4.22%142.07M | 14.89%136.32M | 25.15%118.65M | 10.33%94.8M | 34.97%85.93M |
Income before tax | 47.09%222.23M | -14.55M | -51.83%913.82M | 151.09M | -77.45%1.9B | -16.07%8.41B | -7.09%10.02B | 8.36%10.79B | 143.93%9.96B | 111.17%4.08B |
Income tax | 33.41%100.13M | 31.61M | -14.54%295.28M | 75.05M | -83.53%345.51M | -13.08%2.1B | -18.93%2.41B | 1.84%2.98B | 170.89%2.92B | 34.38%1.08B |
Net income | 60.58%122.1M | -46.16M | -60.14%618.54M | 76.04M | -75.42%1.55B | -17.03%6.31B | -2.57%7.61B | 11.07%7.81B | 134.24%7.03B | 165.76%3B |
Net income continuous Operations | 60.58%122.1M | ---46.16M | -60.14%618.54M | --76.04M | -75.42%1.55B | -17.03%6.31B | -2.57%7.61B | 11.07%7.81B | 134.24%7.03B | 165.76%3B |
Minority interest income | -190.44%-20.69M | -17.28M | 58.44%-25.28M | -7.12M | -74.22%-60.82M | -159.41%-34.91M | -14.89%58.77M | 151.26%69.05M | 236.32%27.48M | 64.98%-20.16M |
Net income attributable to the parent company | 71.71%142.79M | -28.87M | -60.08%643.82M | 83.16M | -74.60%1.61B | -15.92%6.35B | -2.46%7.55B | 10.52%7.74B | 131.77%7B | 154.57%3.02B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 71.71%142.79M | -28.87M | -60.08%643.82M | 83.16M | -74.60%1.61B | -15.92%6.35B | -2.46%7.55B | 10.52%7.74B | 131.77%7B | 154.57%3.02B |
Basic earnings per share | 65.12%0.6 | -0.12 | -60.17%2.76 | 0.3634 | -74.59%6.93 | -15.94%27.2683 | -2.46%32.4375 | 7.06%33.2565 | 123.68%31.0639 | 154.68%13.8878 |
Diluted earnings per share | 65.12%0.6 | -0.12 | -60.17%2.76 | 0.3634 | -74.59%6.93 | -15.94%27.2683 | -2.46%32.4375 | 7.06%33.2565 | 123.68%31.0639 | 154.68%13.8878 |
Dividend per share | -52.80%0.5404 | 0 | -86.57%1.3894 | 1.145 | -27.98%10.3462 | -12.72%14.3658 | 15.01%16.4599 | 29.97%14.3111 | 125.22%11.0107 | 445.29%4.8888 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |